Acyclovir Maintenance Dosing: Three Times Daily Regimen
Yes, acyclovir 200 mg three times daily is a valid maintenance dose for certain indications, specifically as an alternative suppressive regimen for recurrent genital herpes in adults. However, the preferred maintenance dose for most indications is 400 mg twice daily.
Context-Specific Dosing
The three-times-daily maintenance regimen appears in clinical guidelines as an alternative suppressive therapy option for recurrent genital herpes, not as the primary recommendation:
For Recurrent Genital Herpes Suppression:
- Preferred regimen: Acyclovir 400 mg orally twice daily 1, 2
- Alternative regimen: Acyclovir 200 mg orally 3-5 times daily 1
The alternative regimen's goal is to identify the lowest effective dose that provides symptom relief for each patient 1.
For HIV/Opportunistic Infection Prophylaxis:
The 2002 CDC guidelines list acyclovir 200 mg three times daily as a normal maintenance dose for preventing opportunistic infections in HIV-infected persons 3. This represents a lower-intensity prophylactic approach compared to treatment dosing.
Standard Maintenance Dosing by Indication
The FDA-approved maintenance regimens are 2:
- Chronic suppressive therapy for recurrent genital herpes: 400 mg twice daily (up to 12 months, then reassess)
- Episodic treatment of recurrences: 200 mg every 4 hours, 5 times daily for 5 days (not maintenance)
- Acute herpes zoster: 800 mg every 4 hours, 5 times daily for 7-10 days (not maintenance)
Important Clinical Considerations
Twice-daily dosing (400 mg) is strongly preferred over three-times-daily regimens because:
- Better adherence with less frequent dosing
- Equivalent efficacy for suppression 4
- Simpler medication schedule improves long-term compliance
The three-times-daily regimen should be reserved for patients who:
- Experience breakthrough recurrences on 400 mg twice daily
- Require dose titration to find their minimum effective dose
- Have specific clinical circumstances warranting more frequent lower doses
Renal dose adjustment is critical: For patients with creatinine clearance <10 mL/min, reduce to 200 mg every 12 hours 3. Hemodialysis patients should receive 200 mg every 12 hours with the first daily dose administered after dialysis 3.
Duration considerations: After 1 year of continuous suppressive therapy, discontinue to reassess the patient's recurrence rate, as episode frequency often decreases over time 1, 4, 1.